Painkillers Market

Painkillers Market Size, Market Forecast and Outlook By FMI

The painkillers market is expected to expand from USD 75.3 billion in 2025 to USD 108.3 billion by 2035. The market is anticipated to register a 3.7% CAGR during the forecast period. Opioids are likely to lead with a 41.6% share in 2025, and OTC products are projected to account for 57.2% share of the product segment.

Summary of the Painkillers Market

• Demand and Growth Drivers
  • Chronic pain cases are expected to raise demand for effective analgesics across hospitals and outpatient care settings.
  • Post-operative pain management is likely to create steady product use across surgical recovery and clinical treatment pathways.
  • Self-medication for minor pain conditions is anticipated to increase OTC product uptake across pharmacies and drug stores.
• Product and Segment View
  • Opioids are expected to lead the drug class segment as controlled use continues in severe pain treatment.
  • OTC products are likely to dominate the product segment as consumers prefer accessible relief for common pain conditions.
  • Surgical pain is anticipated to create strong demand as procedure volumes increase across elective and emergency care.
• Geography and Competitive Outlook
  • North America is expected to account for strong demand through advanced pain management practices and reimbursement access.
  • Europe is likely to see steady adoption as regulated prescribing and patient safety standards guide product use.
  • Companies with safer formulations and broad retail access are anticipated to strengthen their market position through 2035.
• Analyst Opinion
  • Sabyasachi Ghosh, Principal Consultant for Healthcare at FMI, suggests, “The painkillers market is expected to favor companies balancing effective pain relief with patient safety. OTC brands and regulated prescription portfolios are likely to gain advantage as healthcare systems focus on accessible treatment and controlled opioid use.”
• Painkillers Market Value Analysis
  • The painkillers market is shifting from broad analgesic availability toward safer and better-monitored pain relief practices.
  • Demand is likely to rise as chronic disease burden increases across aging populations and long-term care settings.
  • Adoption is expected to improve as OTC products serve routine pain needs through pharmacies and drug stores.
  • Spending is anticipated to increase as healthcare providers prioritize post-surgical recovery and chronic pain management.

Key Takeaways, Market Size, and Forecast

• The painkillers market is expected to reach USD 75.3 billion in 2025 through steady analgesic demand.
• By 2035, the painkillers market is projected to reach USD 108.3 billion across global healthcare settings.
• From 2025 to 2035, the market is anticipated to expand at a 3.7% CAGR.
• Opioids are likely to account for 41.6% share of the drug class segment in 2025.
• OTC products are expected to hold 57.2% share of the product segment in 2025.
• North America is projected to record strong demand across prescription pain management and OTC analgesic use.

 

Metric	Value
Painkillers Market Estimated Value in (2025 E)	USD 75.3 billion
Painkillers Market Forecast Value in (2035 F)	USD 108.3 billion
Forecast CAGR (2025 to 2035)	3.7%

Rationale for Segmental Growth in the Painkillers Market

The painkillers market is expanding steadily as rising cases of chronic illnesses, post operative pain management needs, and lifestyle related conditions drive consistent demand for effective analgesics. Advancements in pharmaceutical formulations and improved accessibility to both prescription and over the counter medications are strengthening adoption worldwide.

The growing preference for self medication in minor pain conditions and the availability of generic variants at affordable costs are further accelerating uptake. Regulatory efforts to balance accessibility with the prevention of misuse, especially for opioids, are shaping product innovation and compliance strategies across the market.

The future outlook remains positive as healthcare systems prioritize both effective pain management and patient safety, creating opportunities for personalized therapies and safer alternatives in pain relief.

Segmental Analysis

Insights into the Opioids Drug Class Segment

The opioids segment is projected to contribute 41.60% of total revenue by 2025 within the drug class category, making it a significant segment in the market. This growth is being driven by their effectiveness in managing moderate to severe pain, particularly in cases where other analgesics fail to provide adequate relief.

The continued use of opioids in controlled medical environments, especially for cancer and post surgical patients, has supported their adoption. Regulatory measures and monitoring frameworks have been reinforced to ensure safe usage while minimizing risks of dependency.

The balance between therapeutic necessity and controlled accessibility has maintained opioids as a cornerstone in clinical pain management, supporting their strong revenue share in the painkillers market.

Insights into the OTC Products Segment

The OTC products segment is expected to account for 57.20% of total revenue by 2025 under the product category, making it the leading segment. The high share is attributed to the widespread use of OTC painkillers for mild to moderate conditions such as headaches, muscle aches, and joint pain.

Consumer preference for self management, coupled with the ease of availability in pharmacies and retail outlets, has driven rapid adoption. The segment also benefits from affordability and the presence of multiple well established brands that cater to diverse demographics.

Increasing awareness about preventive healthcare and lifestyle management has reinforced the demand for OTC solutions, positioning this category at the forefront of market growth.

Insights into the Surgical Pain Indication Segment

The surgical pain segment is projected to hold 39.80% of total revenue by 2025 within the indication category, making it a leading application area. Rising surgical volumes across elective and emergency procedures have contributed significantly to the growing demand for pain management solutions.

Enhanced recovery protocols, which emphasize effective post operative pain control, have supported the use of both prescription and OTC products in this segment. The segment has also gained traction as minimally invasive procedures continue to expand globally, requiring targeted and efficient pain relief strategies.

As surgical interventions increase in frequency due to aging populations and lifestyle related health conditions, the demand for painkillers tailored to surgical pain management continues to dominate.

2020 to 2025 Sales Analysis of Painkillers Vs Forecast for 2025 to 2035

The market value for painkillers was around 4.8% of the overall ~USD 1,400.5 Billion of the global pharmaceuticals market in 2025.

An increasing number of patients suffering from chronic diseases such as cancer and chronic obstructive pulmonary disease (COPD), various prescription drugs for postoperative pain management, and various traumas leading to pain are expected to fuel the growth of global market for painkillers.

• According to the American Cancer Society, an estimated 72.6 million new cases of cancer were detected in the United States in 2024.
• According to the National Cancer Institute, pain occurs in 20% to 50% of cancer patients. About 80% of patients with advanced cancer experience moderate to severe pain. By 2035, the number of cancer cases in the USA is expected to increase to 2.3 million, largely due to an aging population.

Certain health conditions such as diabetes, cancer, and autoimmune diseases are known to increase the risk of developing chronic pain and neuropathic pain. Therefore, it is important that healthcare providers are aware of the increasing prevalence of these conditions and provide appropriate treatment strategies to improve patients’ quality of life.

Overall, the global market is projected to expand at a CAGR of 3.7% during the forecast period (2025 to 2035).

What Are the Key Opportunities for Painkiller Manufacturers?

The regulatory scenario for painkillers can have a significant impact on the growth of the market. In recent years, opioid pain medications have come under increased scrutiny, resulting in stricter regulations and restrictions on their use. This has created opportunities for non-opioid pain medications such as NSAIDs and other non-narcotic medications to gain market share. In addition, regulatory initiatives to improve pain management and reduce opioid abuse, such as prescription drug monitoring programs and physician education programs, may create opportunities for companies offering alternative pain management solutions.

Overall, the regulatory scenario for painkillers is complex and evolving. However, regulatory initiatives that promote safe and effective pain management can create growth opportunities for the painkillers manufacturers, especially for companies that offer innovative solutions.

The companies that navigate the regulatory landscape and invest in innovative solutions to meet the evolving needs of patients and healthcare providers offer lucrative growth opportunities for the market and will raise the market to new heights during the forecast period from 2025 to 2035.

What Are the Major Restraints in the Global Painkillers Market?

Per capita use of opioids is low in Asian countries. According to the Global Opioids Policy Initiative (GOPI), some of the main factors responsible for low opioid use in Asia and Africa include: full patient cost coverage is required, patient registration required before prescribing opioids, and physicians must obtain special permission to prescribe opioids.

The availability of painkillers in Asian and African countries may have a significant impact on the growth of the painkiller market in these regions. In many of these countries, access to painkillers is limited due to various factors such as lack of infrastructure, regulatory issues, and economic constraints. This can lead to a significant unmet need for painkillers, which can ultimately impact the growth of the market.

These factors are negatively impacting the growth of the painkillers market in Asia and Africa and projections have been made which are restraining the growth of the market during the forecast period from 2025 to 2035 in the world.

Country-Wise Insights into Painkiller Consumption and Demand

What Makes the USA a Large Market for Painkillers?

With a market share of 91.5% in 2025, the USA will continue to dominate the North American region. This large market share is expected to continue throughout the forecast period.

In the USA, palliative care facilities are provided in accordance with government and commercial reimbursement guidelines. Palliative care programs in hospitals in the USA include dedicated inpatient palliative care units and palliative care consultation teams.

Also, the American Chronic Pain Association has designated September as Pain Awareness Month, and more than 80 organizations and healthcare professionals, and consumer groups have supported the initiative. This will result in the propulsion of demand for painkillers in the country during the forecast period of 2025 to 2035.

What is the Outlook of Germany Market?

Germany dominates the Western European region with a total market share of about 25.6% in 2025 and is expected to continue to experience the same growth throughout the forecast period.

In Germany, there is a growing interest in personalized medicine, which is also reflected in the painkillers market. Pharmaceutical companies are developing painkillers tailored to specific patient groups, such as the elderly or people with kidney problems, in order to achieve more targeted and effective pain relief. This will foster profitable market growth over the course of the forecast period.

What is the Stance of Japan within the Painkillers Market Space?

Japan dominates the East Asia region with market share of 45.1% in 2025 and will expand with growing numbers in the future.

Japan has taken various initiatives to improve pain management, including the establishment of pain clinics, the development of clinical guidelines for pain management, and the training of healthcare professionals in pain management.

The Japan market for painkillers is expected to continue to grow in the coming years, driven by changing demographics, shifting consumer preferences, and increasing investment in pain management R&D all suggest that Japan will continue to be an important market for painkillers.

Category-Wise Insights into the Pain Relief Sector

Which Painkillers Drug Class is Driving Market Growth?

Opioids are expected to present growth at a CAGR of 2.1% throughout the forecast period, with a market share of 53.4% in the global market in 2025.

Opioids are relatively inexpensive compared to some of the newer non-opioid pain medications. Opioids have been used for pain relief for centuries, and many healthcare providers are familiar with their use and feel comfortable prescribing them.

As the demand for non-opioids continues to grow, the market for painkillers is expected to expand significantly in the coming years.

Which Product is Driving Global Market Growth?

Prescription Drugs dominated the global market with a value share of 58.8% in 2025.

Prescription drugs are leading in the global market for painkillers over over-the-counter (OTC) drugs because they are often more effective at providing pain relief for moderate to severe pain. Prescription painkillers are also often covered by health insurance, which can make them more affordable for patients who need them.

Which Indication is Driving Global Market Growth?

Surgical pain is leading the market with a market share of 43.3% in the global market in 2025.

Surgical pain is leading in the market over other indications because surgery is a common cause of acute pain, and pain relief is an important part of the post-surgical recovery process. Many surgical procedures can be painful, and without adequate pain control, patients may experience significant discomfort, which can delay healing and recovery.

Which Route of Administration is Driving Global Market Growth?

The oral route of administration is leading the market with a revenue share of 38.7% in 2025 as oral painkillers are easy to take and can be self-administered, which can make them more convenient for patients and also it is generally less invasive than other routes, such as injections or transdermal patches, which can make it more appealing for patients.

Which Distribution Channel Benefits the Most from the Sales of Painkillers Globally?

Retail pharmacies hold a market share value of 27.5% during the year 2025. Retail pharmacies typically stock a wide range of painkillers, including both prescription and over-the-counter options and they are easily accessible to consumers, which makes it convenient for them to purchase painkillers.

Competitive Landscape of the Painkillers Industry

Key market players in the painkillers market launch their products. This promotional strategy is expected to be highly impactful to enter into the market.

A few of the recent instances include

• In March 2025, Perrigo Company plc received final approval for its Abbreviated New Drug Application from the "FDA" for ibuprofen Tablets and acetaminophen, 250 mg/125 mg.
• In January 2025, Procter & Gamble (P&G) India added new Vicks ZzzQuil NATURA to its existing portfolio of Vicks in India.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the Painkillers market, which are available in the full report.

Scope of the Painkillers Market Report

Attribute	Details
Forecast Period	2025 to 2035
Historical Data Available for	2020 to 2025
Market Analysis	USD Million for Value
Key Regions Covered	North America; Latin America; Western Europe; Eastern Europe; Russia & Belarus; Balkan & Baltic Countries; South Asia & Pacific; East Asia; Central Asia; and Middle East & Africa
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Spain, France, BENELUX, Nordic Countries, Poland, Hungary, Czech Republic, Romania, Russia and Belarus, Balkan & Baltic Countries, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Japan, China, South Korea, Central Asia, Australia and New Zealand, Türkiye, GCC Countries, Kingdom of Saudi Arabia, Israel, North Africa, and South Africa
Key Market Segments Covered	Drug Class, Product, Indication, Route of Administration, Distribution Channel, and Region
Key Companies Profiled	AbbVie Inc. (Allergan plc); Bristol Myers Squibb Co.; Sanofi S.A.; Boehringer Ingelheim International GmbH; Pfizer Inc.; Zydus Lifesciences Ltd. (Cadila Pharmaceuticals); GSK plc.; Abbott Laboratories, Inc.; Novartis AG; Johnson & Johnson (Janssen Pharmaceuticals, Inc.); Sun Pharmaceutical Industries Ltd.; Teva Pharmaceuticals Ltd.; Mallinckrodt Pharmaceuticals; Endo Pharmaceuticals Inc.; Bayer AG; F. Hoffmann-La Roche Ltd.; Procter & Gamble; AstraZeneca; Cardinal Health; Perrigo Company Plc.; Bausch Health Companies Inc.; Viatris; Amneal Pharmaceuticals; Purdue Pharmaceuticals L.P.
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing	Available upon Request

Key Market Segments Covered in Painkillers Industry Research

By Drug Class:

• Opioids
  • Tramadol
  • Oxycodone
  • Hydrocodone
  • Other Opioids
• NSAIDs
• Local Anesthetics
• Acetaminophen

By Product:

• OTC Products
• Prescription Drugs

By Indication:

• Surgical Pain
• Cancer Pain
• Neuropathic Pain
• Musculoskeletal and Joint Pain
• Others

By Route of Administration:

• Injectable
• Oral
• Rectal
• Topical
• Transdermal
• Others

By Distribution Channel:

• Hospital Pharmacies
• Specialty Clinics
• Long Term Care Centers
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Region:

• North America
• Latin America
• East Asia
• South Asia & Pacific
• Western Europe
• Eastern Europe
• Central Asia
• Russia & Belarus
• Balkan & Baltic Countries
• Middle East and Africa